Webinar #32 | “A Pregnant COVID Survivor with ARDS Post-CS”
The University of the Philippines
in partnership with
Philippine Health Insurance Corporation (PhilHealth)
and UP Manila NIH National Telehealth Center
in cooperation with
UP Manila College of Medicine and UP Philippine General Hospital would like to invite you to join the Fight Against COVID-19!
The Webinar Series “STOP COVID DEATHS: VIRTUAL GRAND ROUNDS” – the very first Online Medical Grand Rounds in the Philippines
is scheduled EVERY FRIDAY from 12nn to 2pm.
Webinar #32: “A Pregnant COVID Survivor with ARDS Post-CS”
November 13, 2020 (Friday) 12nn
Dr. Marvic Gabitan
Fellow, Dept. of Pulmonary Critical Care, and Sleep Medicine
Lung Center of the Philippines
Dr. Judith Montero
Fellow, Division of Infectious Diseases
Dept. of Obstetrics and Gynecology
Philippine General Hospital
Opening Remarks: Closing Remarks:
Dr. Vincent Balanag, Jr.
Executive Director
Lung Center of the Philippines
Dr. Stella Marie Jose
Deputy Director for Health Operations
Philippine General Hospital
OB Discussant:
Dr. Maria Angela Bandola
OB Infectious Disease Specialist
Philippine General Hospital
ARDS Discussant:
Dr. Dennis Teo
Specialist, Dept. of Pulmonary Critical Care, and Sleep Medicine
Lung Center of the Philippines
Case Capsule: This case is about a 30-year old nurse, at her 34th month of pregnancy who is exposed to a COVID patient, delivers the baby prematurely, and then develops sepsis.
Based on what we know at this time, pregnant women are at an increased risk for severe illness from COVID-19 compared to non-pregnant people. Additionally, pregnant women with COVID-19 might be at increased risk for other adverse outcomes, such as preterm birth.
There are previous findings that COVID-19 among pregnant women is associated with increased risk for ICU admission and receipt of invasive ventilation among women of reproductive age. Longitudinal surveillance and cohort studies among pregnant women with COVID-19, including information about pregnancy outcomes, are necessary to understand the full spectrum of maternal and neonatal outcomes associated with COVID-19 in pregnancy.
Understanding the risk posed by SARS-CoV-2 infection in pregnant women can inform clinical practice, teaching. training and public health communication. Team approaches are needed when managing pregnant women who may have COVID exposure.
To minimize the risk for acquiring COVID-19, pregnant women should limit unnecessary interactions with persons who might have been exposed to or are infected with SARS-CoV-2, including those within their household, as much as possible. Additionally, pregnant women should take measures to ensure their general health, including staying up to date with annual influenza vaccination and prenatal care.
